LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK

Breast cancer is a common malignancy in women. Acquisition of drug resistance is one of the main obstacles encountered in breast cancer therapy. Long non-coding RNA (lncRNA) has been demonstrated to play vital roles in both development and tumorigenesis. However, the relationship between lncRNAs and...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Xinxin, Zang, Ruochen, Zhang, Erbao, Liu, Yue, Shi, Xiao, Zhang, Ershao, Shao, Lipei, Li, Andi, Yang, Nan, Han, Xiao, Pan, Beijing, Zhang, Zhihong, Sun, Luan, Sun, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348405/
https://www.ncbi.nlm.nih.gov/pubmed/27845892
http://dx.doi.org/10.18632/oncotarget.13263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348405/
https://www.ncbi.nlm.nih.gov/pubmed/27845892
http://dx.doi.org/10.18632/oncotarget.13263

Ejemplares similares